EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CpG Methylation of Protein Prenyltransferase Genes FNTA, FNTB, PGGT1B and RABGGTA in Cancer Cell Lines

Dominik Jung iD, Daniel Diehl iD, Anna Hagemann iD, Hagen Sjard Bachmann

Epigenomes · 04.03.2026 · 10 (1) · 17

DOI: 10.3390/epigenomes10010017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epigenomes, online erschienen am 04.03.2026. Verfasst von Dominik Jung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology and Toxicology, Center for Biomedical Education and Research (ZBAF), School of Medicine, Faculty of Health, Witten/Herdecke…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Protein prenylation is crucial for the function of hundreds of proteins. Aberrant protein prenylation can be caused by the aberrant expression of prenyltransferases (PTases), which has been reported for multiple cancer entities. The reasons for aberrant PTase expression in cancer have not yet been investigated.

Methods

We analyzed CpG methylation within promoter-associated CpG islands of the PTase genes FNTA, FNTB, PGGT1B, and RABGGTA via bisulfite conversion and pyrosequencing to assess its role in PTase expression and gain deeper insight into the regulation of protein prenylation in cancer. We used DNA from three benign controls (whole blood samples, peripheral blood mononuclear cells, and HEK293) and 19 human cancer cell lines from various origins to assess DNA methylation within PTase gene promoter-associated CpG islands. For a subset of these cell lines, we measured mRNA expression via qPCR and correlated it with DNA methylation.

Results

Methylation across all PTase genes ranged from 1.9 ± 0.9% to 11.4 ± 4.0% (mean methylation ± standard deviation) in benign cells, and 2.3 ± 1.0% to 16.0 ± 5.4% in cancer cells. DNA methylation and mRNA expression of PGGT1B correlated inversely (PCC = −0.75; p = 0.005).

Conclusions

We saw no general differences between benign and malignant cells, but observed significant differences between non-malignant controls and multiple individual cancer cell lines regarding the methylation of PTase genes. This was prominently seen in PGGT1B in Caki-1 cells, raising the possibility that DNA methylation is involved in the dysregulation of PTase expression in cancer.

Schlagwörter

Stichwörter der Autor:innen

DNA methylationcancermRNA expressionprenyltransferasesprotein prenylationpyrosequencingqPCRregulation

Autor:innen und Institutionen

  • Institute of Pharmacology and Toxicology, Center for Biomedical Education and Research (ZBAF), School of Medicine, Faculty of Health, Witten/Herdecke University, 58453 Witten, Germany.

ORCID-Profile: Dominik Jung, Daniel Diehl, Anna Hagemann

Zitieren

APA

Jung, D., Diehl, D., Hagemann, A., & Bachmann, H. S. (2026). CpG Methylation of Protein Prenyltransferase Genes FNTA, FNTB, PGGT1B and RABGGTA in Cancer Cell Lines. Epigenomes, 10(1), 17. https://doi.org/10.3390/epigenomes10010017

Vancouver

Jung D, Diehl D, Hagemann A, Bachmann HS. CpG Methylation of Protein Prenyltransferase Genes FNTA, FNTB, PGGT1B and RABGGTA in Cancer Cell Lines. Epigenomes. 2026;10(1):17. doi:10.3390/epigenomes10010017

BibTeX
@article{Jung2026,
  author = {Jung, Dominik and Diehl, Daniel and Hagemann, Anna and Bachmann, Hagen Sjard},
  title = {CpG Methylation of Protein Prenyltransferase Genes FNTA, FNTB, PGGT1B and RABGGTA in Cancer Cell Lines},
  journal = {Epigenomes},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {17},
  doi = {10.3390/epigenomes10010017}
}
Kostenlos starten →